Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y18.44% Shs Outstand Perf Week0.62%
SponsorTema ETF Type Tagsequity Return% 3Y- Total Holdings45 Perf Month-2.52%
Fund Family Bond Type Tagshealthcare Return% 5Y- AUM79.52M Perf Quarter-5.00%
Index- Average Maturity Tagstechnology Return% 10Y NAV% Perf Half Y0.85%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year18.44%
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range27.10 - 36.03 Perf YTD6.83%
Dividend TTM- ESG Type Tags- Flows% 3M-0.37% 52W High-9.24% Beta1.43
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD354.74% 52W Low20.66% ATR (14)0.49
Expense0.75% Structure Type Region Flows% 1Y RSI (14)53.26 Volatility1.16% 1.51%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume1.55 Prev Close32.03
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume14.93K Price32.70
SMA201.88% SMA50-0.70% SMA200-1.68% Trades Volume23,116 Change2.09%
Apr-22-24 11:10AM
Mar-13-24 12:40PM
Tema Cardiovascular and Metabolic ETF seeks to provide long-term growth of capital. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund advisor generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.